Immunosuppression with purine analogues — the flip side of the gold coin
- 1 May 1993
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (5) , 347-348
- https://doi.org/10.1093/oxfordjournals.annonc.a058511
Abstract
Michael J. Keating, M.D; Immunosuppression with purine analogues — the flip side of the gold coin, Annals of Oncology, Volume 4, Issue 5, 1 May 1993, Pages 347Keywords
This publication has 12 references indexed in Scilit:
- Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaAnnals of Oncology, 1993
- Induction of apoptotic cell death in chronic lymphocytic leukemia by 2- chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineBlood, 1993
- Treatment of hairy cell leukemiaBlood, 1992
- 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception MechanismJNCI Journal of the National Cancer Institute, 1989
- 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaBlood, 1988
- Low-dose deoxycoformycin in lymphoid malignancy.Journal of Clinical Oncology, 1985
- T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturationBlood, 1979
- Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenineBiochemical Pharmacology, 1977